- Report
- July 2024
- 80 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- April 2024
- 84 Pages
Japan
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2024
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 177 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2023
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- February 2024
- 123 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 179 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 113 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 102 Pages
India
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 105 Pages
Europe
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 120 Pages
United States
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2023
- 141 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- July 2021
- 255 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- March 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- February 2024
- 164 Pages
Global
From €4516EUR$4,750USD£3,794GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more